Outlook Therapeutics shares owned by Barclays
Quarter-by-quarter ownership of Outlook Therapeutics shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Outlook Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Outlook Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Outlook Therapeutics by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $85k | 216k | 0.39 |
| 2023-09-30 | $6.0k | 27k | 0.22 |
| 2023-06-30 | $54k | 31k | 1.74 |
| 2023-03-31 | $86k | 79k | 1.09 |
| 2022-12-31 | $34k | 32k | 1.07 |
| 2022-09-30 | $6.0k | 5.0k | 1.19 |
| 2022-06-30 | $6.0k | 5.9k | 1.01 |
| 2022-03-31 | $32k | 19k | 1.73 |
| 2021-12-31 | $147k | 108k | 1.36 |
| 2021-09-30 | $79k | 36k | 2.17 |
| 2021-06-30 | $42k | 17k | 2.44 |
| 2021-03-31 | $21k | 9.4k | 2.24 |
| 2020-03-31 | $21k | 35k | 0.60 |
| 2019-12-31 | $21k | 35k | 0.60 |
| 2019-03-31 | $0 | 19 | 0.00 |